263 related articles for article (PubMed ID: 16682800)
1. Intravenous immunoglobulin: striving for appropriate use.
Kumar A; Teuber SS; Gershwin ME
Int Arch Allergy Immunol; 2006; 140(3):185-98. PubMed ID: 16682800
[TBL] [Abstract][Full Text] [Related]
2. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
Elovaara I; Hietaharju A
Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
[TBL] [Abstract][Full Text] [Related]
3. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
Lünemann JD; Quast I; Dalakas MC
Neurotherapeutics; 2016 Jan; 13(1):34-46. PubMed ID: 26400261
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
6. Guidelines on the use of intravenous immune globulin for neurologic conditions.
Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
8. [Immunomodulatory effects of intravenous immunoglobulins].
Kazatchkine M; Mouthon L; Kaveri SV
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
[TBL] [Abstract][Full Text] [Related]
9. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
Gold R; Stangel M; Dalakas MC
Nat Clin Pract Neurol; 2007 Jan; 3(1):36-44. PubMed ID: 17205073
[TBL] [Abstract][Full Text] [Related]
10. The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases.
Zandman-Goddard G; Krauthammer A; Shoenfeld Y
Expert Rev Clin Immunol; 2007 Sep; 3(5):773-80. PubMed ID: 20477027
[TBL] [Abstract][Full Text] [Related]
11. [Intravenous immunoglobulin therapy].
Mouthon L
Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
[TBL] [Abstract][Full Text] [Related]
12. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
[TBL] [Abstract][Full Text] [Related]
13. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
Blanchette VS; Kirby MA; Turner C
Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
[TBL] [Abstract][Full Text] [Related]
14. [Immunoglobulins--merely expensive or also useful?].
Paar WD
Ther Umsch; 1995 Oct; 52(10):639-44. PubMed ID: 7482374
[TBL] [Abstract][Full Text] [Related]
15. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
Linker RA; Gold R
Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
[TBL] [Abstract][Full Text] [Related]
16. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
[TBL] [Abstract][Full Text] [Related]
17. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
Rabie M; Nevo Y
Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
[TBL] [Abstract][Full Text] [Related]
18. New uses for IVIgG immunoglobulin therapies.
Wallington T
Vox Sang; 2004 Jul; 87 Suppl 2():155-7. PubMed ID: 15209904
[No Abstract] [Full Text] [Related]
19. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
[TBL] [Abstract][Full Text] [Related]
20. [Intravenously applied immunoglobulin in systemic, autoimmune and vasculitis diseases in children].
Zeman K; Cywińska-Bernas A
Pol Merkur Lekarski; 2011 Jun; 30(180):400-4. PubMed ID: 21751547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
